<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01500655</url>
  </required_header>
  <id_info>
    <org_study_id>2008P001944</org_study_id>
    <nct_id>NCT01500655</nct_id>
  </id_info>
  <brief_title>Ultrasound-Guided Block of the Lateral Femoral Cutaneous Nerve in Pediatric Patients</brief_title>
  <official_title>Evaluation of Ultrasound-Guided Block of the Lateral Femoral Cutaneous Nerve in Pediatric Patients for Reconstructive Surgical Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether either a peripheral nerve block under
      ultrasound (u/s) guidance of the lateral femoral cutaneous nerve (LFCN), versus an u/s guided
      block of the nerve followed by continuous catheter infusion of local anesthetic, offers
      better post-operative analgesia in pediatric burn patients undergoing reconstructive surgery,
      than the current analgesic regimen of subcutaneous local anesthetic infiltration.

      Eligible subject, pediatric patients having reconstructive surgery for burns, having skin
      graft donor sites of the lateral thighs, will be randomized into three groups: control
      (having local infiltration of site), ultrasound guided nerve block, or ultrasound guided
      nerve block with catheter placement --fascia iliac.

      Post-operative comfort will be assessed over the next 48 hours.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Pain Scale</measure>
    <time_frame>Q4 hours,while awake, for 48 hours</time_frame>
    <description>We will assess a VAS of pain (0-10)--every 4 hours postoperatively while the patient is awake, for 48 hours post-op.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Narcotic use</measure>
    <time_frame>48 hours postoperative</time_frame>
    <description>We will record narcotic requirements of the subjects over the 48 hours post operatively.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An ultrasound guided block of the LFCN is performed, followed by the placement of a catheter underneath the fascia iliaca.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound guided LFCN block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An ultrasound guided regional nerve block --using ropivacaine 0.2%-- will be performed around the lateral femoral cutaneous nerve (LFCN).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group gets the current standard of care--the donor site is infiltrated with 0.25% bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Regional nerve block</intervention_name>
    <description>a block of the lateral femoral cutaneous nerve is performed under ultrasound guidance. For LFCN block, ropivacaine 0.2% will be used. Dose will be 20 ml, unless patient weighs less than 20 kg, in which case volume will be equal to patient's weight in kilograms.</description>
    <arm_group_label>Catheter</arm_group_label>
    <arm_group_label>Ultrasound guided LFCN block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Catheter</intervention_name>
    <description>After an ultrasound guided nerve block is performed a catheter is placed under the fascia iliaca and an infusion of ropivacaine 0.2% running at 0.15 ml/kg/hour is administered for 48 hours.</description>
    <arm_group_label>Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  going for reconstructive surgery requiring split thickness skin graft

          -  patient's donor site will be in distribution of lateral femoral cutaneous nerve

          -  age &gt;=2 and &lt;22

          -  patient emotionally/intellectually able to describe intensity of post-op pain using
             VAS or Wong- Baker faces scale.

        Exclusion Criteria:

          -  potential block/catheter site infected or burned.

          -  intolerance/allergy to local anesthetics

          -  BMI &gt; 30

          -  American Society of Anesthesiologists (ASA) score &gt; 2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik S Shank, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Partners Health Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shriners Hospital for Children</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2011</study_first_submitted>
  <study_first_submitted_qc>December 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2011</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Erik S. Shank, MD</investigator_full_name>
    <investigator_title>Staff Physician: Pediatric Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>burn</keyword>
  <keyword>skin graft donor site</keyword>
  <keyword>analgesia for donor site</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

